Haemodynamic support during high-risk percutaneous coronary intervention - 16/02/22
Support hémodynamique dans le cadre d’angioplasties à très haut risque
Doi : 10.1016/j.acvd.2021.12.002
Vassili Panagides a, Marc Laine a, Julien Mancini b, Clément Delmas c, Melanie Gaubert a, Thibaut Dabry a, Mourad Boufi d, Franck Paganelli a, Gilles Lemesle e, Laurent Bonello a, ⁎ 
a Intensive Care Unit, Hôpital Nord, AP–HM, Aix-Marseille University, 13015 Marseille, France, Mediterranean Association for Research and Studies in Cardiology (MARS Cardio), Centre for CardioVascular and Nutrition Research (C2VN), Inserm 1263, INRA 1260, 13005, Marseille, France
b Department of Public Health (BIOSTIC), Hôpital de la Timone, Aix-Marseille University, 13005, Marseille, France
c Intensive Cardiac Care Unit, Cardiology Department, University Hospital of Rangueil, 31400, Toulouse, France
d Service de chirurgie vasculaire, Hôpital Nord, AP–HM, 13015, Marseille, France
e USIC et centre hémodynamique, Institut Cœur Poumon, Centre Hospitalier Universitaire de Lille, 59000, Lille, France
⁎Corresponding author at: Hôpital Universitaire Nord, chemin des Bourrely, 13015 Marseille, France.Hôpital Universitaire Nordchemin des BourrelyMarseille13015France
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.
Conéctese para beneficiarse!
Keywords : Impella®, High-risk percutaneous intervention, Mechanical assist device, Haemodynamic impairment
Mots clés : Impella, Angioplasties à très haut risque, Système d’assistance mécanique, Instabilité hémodynamique
Abbreviations : HRPCI, LMT, LOP, LVEF, PCI, RCA
El texto completo de este artículo está disponible en PDF.
Esquema
| ☆ | Tweet: Selection of patients for Impella-supported HRPCI is critical. Haemodynamic impairment was present in 41% of our cohort. This research paper describes the clinical characteristics of these patients to guide the utilization of haemodynamic support in HRPCI. |
© 2022
Elsevier Masson SAS. Reservados todos los derechos.
Vol 115 - N° 2
P. 109-113 - février 2022 Regresar al número
Artículo precedente
- Impact of lowering low-density lipoprotein cholesterol thresholds on the proportion of adults requiring an intervention: Application of the 2019 ESC/EAS guidelines for the management of dyslipidaemia to the French population
- Valérie Olié, Clémence Grave, Amélie Gabet
- 18F-fluorodeoxyglucose positron emission tomography/computed tomography imaging for the diagnosis of immune checkpoint inhibitor-associated myocarditis
- Stéphane Ederhy, Perrine Devos, Bruno Pinna, Elisa Funck-Brentano, Baptiste Abbar, Charlotte Fenioux, Ariel A. Cohen, Javid Moslehi, Marie Bretagne, Yves Allenbach, Dris Kharroubi, Joe-Elie Salem
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.